GPC4 and Parkinson disease: The correlation of GPC-4 serum levels and MoCA score values in our study holds the potential to use serum GPC-4 as a molecular biomarker for vascular risk stratification in order to identify PD patients with increased risk of developing dementia, presumably of higher age.